GENESIS Pharma
Costas Evripides is a seasoned executive with extensive experience in the pharmaceutical industry, currently serving as CEO and Founding Member of Genesis Pharma since 1996. Prior to this role, Costas held the position of President and Managing Director at Wellcome Hellas from July 1985 to June 1995. Costas holds an MBA from London Business School, completed between 1983 and 1985, and a degree in Economics from Athens University of Economics and Business, obtained from 1975 to 1979. Early education was completed at English School Nicosia from 1965 to 1972.
This person is not in any offices
GENESIS Pharma
GENESIS Pharma is a regional biopharma company focused on the commercialization of innovative pharmaceutical products for severe and rare diseases in Central and Eastern Europe. Founded in 1997 in Greece, GENESIS Pharma S.A. was among the first pharmaceutical companies in Europe to specialize in the marketing, sales and distribution of biopharmaceutical products. In 1999, business activities were expanded in Cyprus through the creation of GENESIS Pharma (Cyprus) Ltd, and later on, in markets of Southeast Europe. GENESIS Pharma (Cyprus) Ltd, an affiliate (sister) company, now operates in Central and Eastern Europe, through its subsidiaries in Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia (EU) as well as North Macedonia and Serbia (Non-EU). GENESIS Pharma maintains a strong portfolio in therapeutic areas with high unmet medical need through long standing strategic alliances with leading international pharma companies committed to cutting-edge R&D as well as biopharma companies with disruptive innovations for the development of targeted, specialized treatments for orphan diseases. For more information, please visit www.genesispharmagroup.com and www.genesispharma.com